Back to Jacobs Levy Equity Management, Inc. Jacobs Levy Equity Management, Inc.

GILD

Showing 5 of 28 quarters

Position history for Jacobs Levy Equity Management, Inc.Jacobs Levy Equity Management, Inc.'s holdings in Gilead Sciences, Inc.

No. Jacobs Levy Equity Management exited its GILD (Gilead Sciences) position in Q3 2025. Its Q2 2025 13F listed 65,923 shares worth $7.3M. Jacobs Levy Equity Management already held GILD in its Q4 2018 13F, the earliest on record, and held it in 27 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$42.6M

Total Shares Change

-508,291

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$108.32
0
2025-Q2
Decreased
65,923
-46.1%
$7.3M0.0%$107.45
0
2025-Q1
Decreased
122,374
-81.1%
$13.7M0.1%$107.83
0
2024-Q4
Increased
648,386
+27.6%
$59.9M0.2%$88.27
44
2024-Q3
Decreased
508,291
-47.5%
$42.6M0.2%$79.45
0

Other major holders of GILD: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used